|

HFNC Versus NIV in Hypercapneic COPD Patients

RECRUITINGN/ASponsored by Mohammed Shehta
Actively Recruiting
PhaseN/A
SponsorMohammed Shehta
Started2025-11-03
Est. completion2026-11
Eligibility
Age40 Years+
Healthy vol.Accepted

Summary

Aim: To compare gas exchange trends, clinical outcomes, and tolerability between HFNC and NIV in COPD patients with mild-to-moderate hypercapnic respiratory failure.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* COPD patients hospitalized with mild-to-moderate hypercapnic respiratory failure, defined as arterial pH \[range, e.g., 7.25-7.35\] and PaCO2 \[threshold, e.g., \>45 mmHg and less 60 mmHg\].

Exclusion Criteria:

* patients with altered mental state, confused, severe agitation or not cooperative were excluded. Also, severe acidosis (pH \<7.25), hemodynamic instability, facial trauma or surgery, cases with severe nasal deformity, immediate indication for invasive ventilation, patient refusal, cases with respiratory rate more than 35 breaths per minute. Respiratory exhaustion, excess use of respiratory accessory muscles, Patients with breathing disorders during sleep as well as cases of upper airway obstruction and patients with history of chronic home ventilation prior admission were another items for exclusion

Conditions2

COPDCOPD - Chronic Obstructive Pulmonary Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.